Prediction of recurrent venous thromboembolism by measuring ProC Global

Thrombosis and Haemostasis

Volumn 98, Issue 6, 2007, Pages 1232-1236

  Eichinger, Sabine ^a   Hron, Gregor ^a   Hirschl, Mirko ^b   Bialonczyk, Christine ^b   Minar, Erich ^a   Kollars, Marietta ^a   Kyrle, Paul A ^a  

^a MEDICAL UNIVERSITY OF VIENNA   (Austria)

^b Hanuschkrankenhaus ^*  (Austria)

Author keywords

ProC Global; Recurrence; Venous thrombosis

Indexed keywords

PROTEIN C;

ADULT; ARTICLE; ASSAY; CONTROLLED STUDY; FEMALE; FOLLOW UP; HUMAN; MAJOR CLINICAL STUDY; MALE; PARTIAL THROMBOPLASTIN TIME; PATIENT CODING; PLASMA; PREDICTION; PRIORITY JOURNAL; PROBABILITY; PROSPECTIVE STUDY; RECURRENCE RISK; RECURRENT DISEASE; RISK FACTOR; VENOUS THROMBOEMBOLISM;

ADULT; ANTICOAGULANTS; AUSTRIA; FEMALE; FOLLOW-UP STUDIES; HUMANS; MALE; MIDDLE AGED; ODDS RATIO; PARTIAL THROMBOPLASTIN TIME; PREDICTIVE VALUE OF TESTS; PROPORTIONAL HAZARDS MODELS; PROSPECTIVE STUDIES; PROTEIN C; REAGENT KITS, DIAGNOSTIC; RECURRENCE; RISK ASSESSMENT; SENSITIVITY AND SPECIFICITY; TIME FACTORS; VENOUS THROMBOEMBOLISM;

EID: 36949001370     PISSN: 03406245     EISSN: None     Source Type: Journal    
DOI: 10.1160/TH07-05-0376     Document Type: Article

References (20)

1. Mannucci PM. Laboratory detection of inherited thrombophilia: a historical perspective. Semin Thromb Hemost 2005; 31: 5-10.
2. Palareti G, Legnani C, Cosmi B, et al. Risk of venous thromboembolism recurrence: high negative predictive value of D-dimer performed after oral anti-coagulation is stopped. Thromb Haemost 2002; 87: 7-12.
3. Eichinger S, Minar E, Bialonczyk C, et al. D-dimer levels and risk of recurrent venous thromboembolism. J Am Med Assoc 2003; 290: 1071-1074.
4. Tripodi A, Chantarangkul V, Martinelli I, et al. A shortened activated partial thromboplastin time is associated with the risk of venous thromboembolism. Blood 2004; 104: 3631-3634.
5. Hron G, Eichinger S, Weltermann A, et al. Prediction of recurrent venous thromboembolism by the activated partial thromboplastin time. J Thromb Haemost 2006; 4: 750-751.
6. Brummel-Ziedins KE, Vossen CY, Butenas S, et al. Thrombin generation profiles in deep venous thrombosis. J Thromb Haemost 2005; 3: 2497-2505.
7. Hron G, Kollars M, Binder BR, et al. Identification of patients at low risk for recurrent venous thromboembolism by measuring thrombin generation. J Am Med Assoc 2006; 296: 397-402.
8. Eichinger S, Hron G, Weltermann A, et al. Endogenous thrombin potential (ETP) for assessing the risk of recurrent venous thromboembolism. Blood 2005; 106: 1622A.
9. Dati F, Hafner G, Erbes H, et al. ProC Global: the first functional screening assay for the complete protein C pathway Clin Chem 1997; 43: 1719-1723.
10. Grand'Maison A, Bates SM, Johnston M, et al. "ProC Global"; a functional screening test that predicts recurrent venous thromboembolism. Thromb Haemost 2005; 93: 600-604.
11. Kyrie PA, Minar E, Bialonczyk C, et al. The risk of recurrent venous thromboembolism in men and women. N Engl J Med 2004; 350: 2558-2563.
12. Brandt JT, Triplett DA, Alving B, et al. Criteria for the diagnosis of lupus anticoagulants: an update. Thromb Haemost 1995; 74: 1185-1190.
13. Kalbfleisch JD, Prentice RL. The statistical analysis of failure time data. New York, NY: John Wiley & Sons; 1980.
14. Kaplan EL, Meier P. Nonparametreic estimation from incomplete observations. J Am Stat Assoc 1958; 53: 457-481.
15. Schulman S, Ogren M. New concepts in optimal management of anticoagulant therapy for extended treatment of venous thromboembolism. Thromb Haemost 2006; 96: 258-266.
16. Mannucci PM. The measurement of multifactorial thrombophilia. Thromb Haemost 2002; 88: 1-2.
17. Kraus M, Noah M, Fickenscher K. The PCAT - a simple screening assay for assessing the functionality of the protein C anticoagulant pathway. Thromb Res 1995; 79: 217-222.
18. Toulon P, Halbmeyer WM, Hafner G, et al. Screening for abnormalities in the protein C anticoagulant pathway using the ProC Global assay. Results of a European multicenter evaluation. Blood Coag Fibrinol 2000; 11: 447-454.
19. Sarig G, Aberbach I, Schliamser L, et al. Evaluation of ProC Global assay in women with a history of venous thromboembolism on hormonal therapy Thromb Haemost 2006; 96: 578-583.
20. Buller HR, Agnelli G, Hull RD, et al. Antithrombotic therapy for venous thromboembolic disease: the Seventh ACCP Conference on Antithrombotic and Thrombolytic Therapy. Chest 2004; 126: 401S-428S.